← Eichor
Condition: Dialysis Complications Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Dialysis Complications

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dietary Potassium Liberalization in Pre-Dialysis Patients
NA · 2 location(s) · University of Manitoba · NCT05090865Activation of the Contact System and the Immune System in Patients With Chronic Kidney Disease.
Phase N/A · 1 location(s) · Odense University Hospital · NCT05266092Intradialytic Exercise With Blood Flow Restriction in Hemodialysis Patients
NA · 2 location(s) · University of Avignon · NCT07269379Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients
NA · 2 location(s) · University of Pittsburgh · NCT06978127CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
Phase 3 · 8 location(s) · VA Office of Research and Development · NCT05931276Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients.
NA · 1 location(s) · Oman Ministry of Health · NCT07491042Evolution of Bone Histomorphometry and Vascular Calcification Before and After Renal Transplantation
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT01886950Access Cannulation Trial II
NA · 8 location(s) · Voyager Biomedical · NCT05490225Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis
Phase 4 · 1 location(s) · Chinese PLA General Hospital · NCT07045155Quality of Life in Patients Transitioning to Home or In-Center Dialysis (QUALIFY CKD-to-HOME)
Phase N/A · 1 location(s) · Ciusss de L'Est de l'Île de Montréal · NCT06458322A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
Phase N/A · 25 location(s) · Takeda · NCT06243731New Biomarkers of Bone Mineral Metabolism as Cardiovascular Risk Factors in Chronic Kidney Disease Patients
NA · 7 location(s) · University Hospital, Montpellier · NCT02808572A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)
Phase 1 · 1 location(s) · CSL Behring · NCT07619820Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Ma
Phase 4 · 21 location(s) · Chengdu Qingshan Likang Pharmaceutical Co., Ltd · NCT06597201The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations
Phase N/A · 2 location(s) · University of Copenhagen · NCT07312981Integrating BIA and eGFR for Nutritional Status in Hemodialysis Patients
Phase N/A · 1 location(s) · University of Tartu · NCT06873880Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
Phase 2 · 18 location(s) · Dicerna Pharmaceuticals, Inc., a Novo Nordisk company · NCT04580420Evaluation of HEArt invoLvement in Patients With FABRY Disease
Phase N/A · 1 location(s) · Wuerzburg University Hospital · NCT03362164Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney
NA · 38 location(s) · SeaStar Medical · NCT05758077Peritoneal Dialysis Registration System (PERSIST)
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT02989298Pleth Variability Index for Predicting Low Blood Pressure During Maintenance Hemodialysis
Phase N/A · 1 location(s) · First Affiliated Hospital of Wannan Medical College · NCT07022847Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filte
Phase N/A · 2 location(s) · Fresenius Medical Care Deutschland GmbH · NCT05282732Pumpkin Seed Oil as a Nutraceutical for Hemodialysis Patients
NA · 1 location(s) · Al-Mustansiriyah University · NCT07710183meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
Phase 3 · 1 location(s) · University Health Network, Toronto · NCT05715814DIALysis With EXpanded Solute Removal
NA · 1 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT06660277Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
Phase 3 · 34 location(s) · Region Stockholm · NCT05679024Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis
Phase 2 · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06913647β2M Post-HD Rebound Prediction
Phase N/A · 1 location(s) · East and North Hertfordshire NHS Trust · NCT07713680Comparative Study of Prognosis and QOL Between APD-RPM and CAPD
Phase N/A · 1 location(s) · Chinese PLA General Hospital · NCT05738525Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients
Phase 2 · 1 location(s) · Chinese University of Hong Kong · NCT06483074
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.